1Cell.Ai India

@1Cell_Ai

1Cell.Ai is an AI-powered precision oncology company revolutionizing liquid biopsy, single-cell multiomics & digital pathology.

India 1Cell.ai Joined July 2025

6 Following 13 Followers 208 Posts

Latest posts 5

Pinned post

1Cell.Ai India @1Cell_Ai Sep 10

1Cell.Ai Inc. has been named Best Healthcare Start-Up 2026 at the 5th CII WR Health Innovation Awards.

Grateful to the clinicians, patients, and families who trust us with hard calls. This recognition strengthens our commitment to earning that trust every day. 🙏

1Cell.Ai India @1Cell_Ai 2d

Sustained proliferative signalling is a recognised cancer hallmark, but cancer biology is considerably more complex than excessive growth alone.

#2 - of memo-therapy

1Cell.Ai India @1Cell_Ai 5d

Awareness saves lives. Early detection makes a difference. 💙

This National Cancer Awareness Day, let's spread awareness and support every cancer journey.

At 1Cell.Ai, we're advancing precision oncology for better-informed cancer care.

#CancerAwarenessDay

1Cell.Ai India @1Cell_Ai 6d

Memo-therapy
#1 ...

#cancer #PrecisionOncology

1Cell.Ai India @1Cell_Ai Oct 31

The chemo has done its job. The scans are clear and the tumor is quiet.
.
Then comes the question patients rarely get a straight answer to:
𝙒𝙝𝙖𝙩 𝙣𝙤𝙬?
. #FDAApprovals #FDA #Cancer #PrecisionOncology

1Cell.Ai India @1Cell_Ai Oct 31

For HER2-+ve metastatic breast cancer, "𝙢𝙖𝙞𝙣𝙩𝙚𝙣𝙖𝙣𝙘𝙚" has meant continuing trastuzumab + pertuzumab.

On Oct 7, the FDA added a third drug: 𝙩𝙪𝙘𝙖𝙩𝙞𝙣𝙞𝙗 (𝙏𝙪𝙠𝙮𝙨𝙖), an oral pill that blocks HER2 from a different angle, now approved as first-line maintenance.

View quoted post on X